Jason Rickard - 15 Aug 2022 Form 4 Insider Report for IRONWOOD PHARMACEUTICALS INC (IRWD)

Role
SVP, Chief Operating Officer
Signature
/s/ Ronald Silver, Attorney-in-Fact
Issuer symbol
IRWD
Transactions as of
15 Aug 2022
Net transactions value
-$11,699
Form type
4
Filing time
17 Aug 2022, 16:05:26 UTC
Previous filing
10 Aug 2022
Next filing
16 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRWD Class A Common Stock Sale $11,699 -994 -0.26% $11.77 375,736 15 Aug 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on September 4, 2018.